{"id":"NCT02378506","sponsor":"Pfizer","briefTitle":"Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects","officialTitle":"A Single-arm, Open-label Study To Assess The Immunogenicity, Safety, And Efficacy Of Etanercept Manufactured Using The High Capacity Process Administered To Subjects With Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-04","primaryCompletion":"2016-05","completion":"2016-06","firstPosted":"2015-03-04","resultsPosted":"2017-05-15","lastUpdate":"2017-05-15"},"enrollment":188,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Rheumatoid"],"interventions":[{"type":"BIOLOGICAL","name":"etanercept","otherNames":[]}],"arms":[{"label":"ETN 50mg QW","type":"EXPERIMENTAL"}],"summary":"Open-label immunogenicity, safety and efficacy study of etanercept manufactured using the high capacity process. Descriptive results will be provided however a formal hypothesis will not be tested in this trial.","primaryOutcome":{"measure":"Percentage of Participants With Positive Etanercept Anti-Drug Antibody (ADA) Status at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"Etanercept","deltaMin":1.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":31,"countries":["Bulgaria","Croatia","Germany","Greece","Hungary","Poland","Serbia","Slovakia","South Africa"]},"refs":{"pmids":["30451655"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=B1801359&StudyName=Study%20to%20Assess%20the%20Immunogenicity%2C%20Safety%2C%20and%20Efficacy%20of%20Etanercept%20Manufactured%20Using%20the%20High%20Capacity%20Process%20Administered%20to%20Rh"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":187},"commonTop":["Injection site erythema","Nasopharyngitis","Upper respiratory tract infection","Injection site pruritus","Fatigue"]}}